Cancer prevention and control committee

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 3, 2001, Pages 113-119

  Scarantino, Charles ^a,i   Berk, Lawrence ^a   David, Frederick ^b   Fisher, Jackie ^c   Griffin, Patricia ^d   Hartsell, William ^e   Konski, Andre ^a   Kuske, Robert ^f   Mack, Curtis ^g   Pilipich, Miljenko ^h   Scott, Charles ^j   Sperduto, Paul ^k  

^a Outcomes Committee Liaison   (United States)

^b New Investigators Committee Liaison   (United States)

^c Research Associates Committee Liaison   (United States)

^d Gastrointestinal Cancer Committee Liaison   (United States)

^e Lung Cancer Committee Liaison   (United States)

^f Breast Cancer Working Group Liaison   (United States)

^g Head and Neck Cancer Committee Liaison   (United States)

^h Genitourinary Cancer Committee Liaison   (United States)

ⁱ Translational Research Program Liaison   (United States)

^j Statistician   (United States)

^k Brain Tumor Committee Liaison   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMIFOSTINE; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CAPTOPRIL; CYTOKINE; EMBRIL; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; ISOFLAVONE; KERATINOCYTE GROWTH FACTOR; NATALIZUMAB; PENTOXIFYLLINE; PLACEBO; PLANT EXTRACT; RECEPTOR BLOCKING AGENT; RETINOIC ACID; ROVELIZUMAB; SELENIUM; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; SUCRALFATE; TRANSFORMING GROWTH FACTOR BETA1; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; WOBE MUGOS EXTRACT;

ALTERNATIVE MEDICINE; BREAST CANCER; CACHEXIA; CANCER; CANCER CONTROL; CANCER PREVENTION; CANCER RESEARCH; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FATIGUE; GASTROINTESTINAL SYMPTOM; GINSENG; HEAD AND NECK CANCER; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; LUNG CANCER; LUNG DISEASE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; XEROSTOMIA; ARTICLE; FORECASTING; HEAD AND NECK TUMOR; LUNG TUMOR; MALE; METHODOLOGY; NEOPLASM; ONCOLOGY; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; PROSTATE TUMOR; RADIATION INJURY;

CLINICAL TRIALS; FORECASTING; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MEDICAL ONCOLOGY; NEOPLASMS; ORGANIZATIONAL OBJECTIVES; PROFESSIONAL STAFF COMMITTEES; PROSTATIC NEOPLASMS; RADIATION INJURIES; RESEARCH DESIGN;

EID: 0035224924     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01792-8     Document Type: Article

References (2)

1. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey
2. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin